ABSTRACT
INTRODUCTION
PCNA is a nuclear protein of about 36kDa which is abundant in the nuclei of proliferating cells but undetectable in non-dividing cells (1, 2, 3) . A Hela cell protein with similar properties was described independently by Bravo and Celis and called Cyclin (4) . The two proteins later proved to be identical (5) . PCNA levels increase several-fold immediately before the onset of S phase when quiescent cells are stimulated by serum and growth factors (6) . Experiments combining the use of DNA synthesis inhibitors with immunofluorescence methods have shown that PCNA synthesis can take place independently of DNA replication although the characteristic discrete or 'punctate' distribution of PCNA-related fluorescence only appears when DNA replication is permitted (7) . A similar characteristically speckled distribution of fluorescence in S-phase nuclei treated with antibodies to PCNA derived from patients with systemic lupus erythromatosus has been reported by Takasaki et ol. (2) . These results suggest a distribution congruent with active sites of chromosomal DNA replication.
Antisense oligonucleotides to parts of the human PCNA sequence lower the mitotic index and inhibit cellular DNA synthesis in Balb/c3T3 cells and this is accompanied by a reduction in the levels of PCNA-related immunofluorescence (8) . These results suggest that PCNA may play a key part in the regulation of DNA replication and cell cycle progression.
PCNA/cyclin was directly implicated in DNA replication when it was shown to be an essential requirement for coordinated leading and lagging strand DNA replication in the in vitro SV40 DNA replication system (9) and that it has identity with the auxilliary factor which confers processivity on DNA polymerase 5 (10, 11) . Recently a detailed examination of the transition from initiation to extended DNA replication in the SV40 in vitro replication system has revealed that PCNA associates with the replication factor RF-C and ATP at the 3'OH terminus of the first Okazaki fragment to be synthesised from the origin thus facilitating a switch from a polymerase-to 5 polymerase-mediated DNA synthesis (12, 13) .
Sequence data are now available for genes encoding PCNAs of the rat (14) , human (15) , Xenopus (16) , Drosophila (17) , Saccharomyces (18) and Schizosaccharomyces pombe (19) . The genes of mammals and Drosophila show a high degree of sequence similarity and predict proteins of about 260 residues with a high content of aspartic and glutamic acids. The predicted M r in the region of 30kDa accords well with more recent estimates from SDS-PAGE.
Our laboratory is currently involved in studying DNA replication in the malarial parasite, Plasmodium falciparum. Replication takes place at four points in the life cycle two of which occur in the human host, in the hepatocytes and, later, in the erythrocytes. We hope that a better understanding of DNA replication in the parasite may have useful practical consequences for the identification of novel drug targets but it may also clarify some questions of a more fundamental nature which relate to the high AT base composition of malarial DNA and the genetic variability of the organism. As part of this program we have cloned and are studying replisome components of the parasite. In a recent paper (20) we reported the full sequence of DNA polymerase S and die core region of DNA polymerase a from P.falciparum. Here we report on the cloning and molecular characterisation of the P.falciparum homologue of PCNA.
MATERIALS AND METHODS

Parasite culture
The Kl isolate of P.falciparum was used in this study. Parasites were cultured in accordance with the method of Trager and Jensen (21) as modified by Zolg et al. (22) . Where required, cultures were synchronised using the method of Lambros and Vanderberg (23) . Briefly, parasitised erythrocytes at high parasitaemia were resuspended in aqueous 5 % D-sorbitol at room temperature for 5 minutes before replacing the sorbitol with growth medium. This treatment destroys erythrocytes harbouring parasites at all growth stages other than ring forms, the first morphologically distinguishable post-invasion erythrocytic form. A second sorbitol treatment was applied eighteen hours after the first to try to improve the synchrony still further. This eliminates any early trophozoites which have developed from late ring forms present after the first sorbitol treatment. The first synchronised samples to be taken correspond to about 20 hours post-invasion of the erythrocytes.
DNA and RNA isolation and blotting techniques
The memods used for the isolation of DNA (24) and RNA (25, 26) and for Southern (27) and Northern (26) blotting have already been described elsewhere.
Cloning and sequencing procedures
Oligonucleotides were designed to correspond with the limited regions of the PCNA polypeptide sequences which are conserved in yeast and human taking into account the A-T bias of P.falciparum DNA. These were used first to probe Southern blots of genomic DNA digested with either EcoRl or HiruSE and then to probe libraries of HiruSE genomic DNA fragments cloned into XNM1149 (28) according to the method of Benton and Davis (29) . Tetramethylammonium chloride was used during washes to equalise the contributions of A-T and G-C base pairs to the T m value (30) . Several oligonucleotides were tried unsuccessfully. The successful probe was an 18-mer with the following composition, (AGT)AT(CT)TT(AGTC)GG(AG CT)GCTAA(AG)TA. This was designed to be complementary to the sequence encoding the conserved amino acid sequence Y/FLAPKI/F (underlined in Fig 2) , situated near the carboxy terminus of these PCNAs. The cloned fragment recognised by this probe was subcloned either into pUBS 1 (31) or pUC19 (32) and the fragments sequenced by the chain termination method (33) using a Sequenase kit (USB). Sequence comparisons were made using the University of Wisconsin Genetics Computer Group (UWGCG) programmes (34) .
Pulsed field gel electrophoresis and chromosome mapping
Pulsed field gel electrophoresis was used to separate the chromosomes of P.falciparum following established protocols (20) . Chromosome blots were prepared using Genescreen Plus membranes. Prehybridisation and subsequent processing were carried out in accordance with the makers' instructions. Probes for chromosomal identification (35, 36) were a gift of Dr T.Wellems and Jane Carlton.
Fusion protein constructs and antibody production
A construct (123-1) was made in which theSau3Al-£coRl fragment (Fig 1) encoding aminoacids 63 to 239 (64% of full length PfPCNA) was cloned into the pGEXl expression vector (37) cut with BamH I and EcoSI in frame with the glutathione-S-transferase open reading frame. The in-frame structure of the construct was verified by sequencing before transforming it into E.coli BL21 for expression studies. 0.1 mM IPTG was used to induce the fusion protein which was visualised after fractionating the cell proteins by SDS-PAGE (38) by staining with Coomassie Blue.
To raise antibodies, the induced fusion protein was gel purified and the protein band excised from the gel. The material was homogenised with an equal volume (0.5ml) of Freund's complete adjuvant and used to immunise a rabbit. A booster immunisation was given three weeks after the first using incomplete adjuvant and blood was collected 13 days later. The serum was used for western blot analysis of parasite extracts and for immunofluorescence analysis of parasites at different stages of erythrocytic development.
Immunofluorescence analysis
Indirect immunofluorescence was done on smears of infected blood (3-8% parasitaemia) prepared on microscope slides and fixed with acetone before use. The method used was essentially that of Hall et al. (39) . The anti-PfPCNA serum was allowed to react with infected blood for one hour in a moist container. The slides were washed then reacted widi fluorescin isodiiocyanate (FITC) conjugate of goat anti rabbit IgG (Sigma F0511) and counter stained with the nuclear stain DAPI.
RESULTS
Cloning and sequencing the PCNA gene
The PCNA gene was isolated as a 4.4kb fragment cloned from a genomic library of HindUl fragments in XNM1149 (clone 120-2, Fig.l) .The fragment was subcloned into pUC19 and sequenced with the oligonucleotide used in the initial screen together with the pUC19 standard primers. Additional oligonucleotide primers were synthesised as required to complete the sequence in both strands. The entire coding sequence proved to be located towards one end of the 4.4 kb fragment; only fifteen bases of upstream sequence separated die initiation codon from the end of the fragment (Fig. 1) . A 726 bp EcoRl-Hindm subfragment containing most of the PfPCNA coding sequence was used to isolate a clone containing an overlapping £coRl 2.3 kb clone from a genomic library of EcoRl fragments in XNM1149 (clone 126-X, fig. 1 ). This contained the 5' terminus of the coding sequence and approximately 1.5 kb of its 5' flanking region. Fig. 1 shows the relationship between these fragments and the locations of the relevant restriction sites. PfPCNA is encoded by an open reading frame of 825 nucleotides which predicts a polypeptide of 275 residues (M r = 30,586Da); slightly longer than other known PCNA sequences. There appear to be no introns. The predicted amino acid sequence is shown in figure 2 . Figure 2 also shows an alignment of the PfPCNA amino acid sequence widi the homologous sequences of Saccharomyces cerevisiae, Xenopus laevis, Drosophila melanogaster and Human. There is ~60% sequence similarity (identical residues plus conservative replacements) between the P.fakipanan and human sequences. The corresponding figure for P.julciparum and yeast is -57%. The invariant residues are dispersed throughout the amino acid sequence. There is little pronounced clustering of conserved residues. About 15 extra amino acids are present in PfPCNA in comparison with these other PCNAs. Most are in a block of 9-10 residues near the carboxy terminus.
Comparison with other species
Chromosomal location
The chromosomes of the parasite were separated by pulse field gel electrophoresis and blotted. The blots were probed with the HinSSl-EcoRl fragment containing most of the PfPCNA coding sequence. The results are shown in Fig 3. The coding sequence for PfPCNA appears to be present as a single copy (Southern blot analysis: data not shown) and is located on the 3.2 megabase fragment 13. This assignment was subsequendy confirmed by reprobing the same blot with the chromosome 13 marker TRAP1 (36) .
Transcript size When the same probe was used to probe a blot of poly (A) + RNA prepared from unsynchronised blood stage parasites, a band Nucleic Acids Research, 1993, Vol. 21 (Fig. 4) . From the size of this band it would appear that the coding sequence for PfPCNA has flanking regions which, togedier, equal me size of the coding sequence itself. Large messages relative to coding sequence have been noted for some other P.Jhlciparum genes (20, 26) . In several RNA preparations a second, minor, message was found at -2.2kb. The significance of this band is at present unknown.
Antibody studies with PfPCNA
A prominent fusion protein product of the expected size (~50kDa) was obtained when E.coli BL-21 harbouring construct 123-1 was induced with IPTG. Its appearence was accompanied by simultaneous disappearence of the glutathione-S-transferase band from these extracts. The fusion protein was insoluble but it was gel purified and the gel-purified material used to raise antisera. Pre-immune and immune sera were used to analyse western blots of total parasite extracts. As shown in figure 5 the immune serum detects a single band at about 32kDa which is absent from pre-immune material. This is in good agreement with the size of the polypeptide predicted from the coding sequence.
Expression of PfPCNA during parasite growth
During its growth in the human erythrocyte the parasite passes through a series of morphologically distinct phases. The first of these, the ring form, appearing immediately after invasion, starts to feed on the cytoplasm of the host erythrocyte and passes through the trophozoite stage before undergoing several nuclear divisions to give the schizont. The schizont matures to produce invasive merozoites which are released from the ruptured erythrocyte. The whole cycle takes about 48 hours.
In in vitro cultures synchronised at the early ring stage, ring forms start to diminish in number after about six hours and thenloss is accompanied by an increase in the number of trophozoites. This reaches its peak about 24hrs after synchrony is established. Schizonts start to appear at about 18hrs after synchronisation and continue to increase until 36hrs. DNA replication accompanies schizont formation (40) .
In order to study the expression of PfPCNA during intraerythrocytic growth, in vitro cultures of P.falciparum were synchronised using 5 % sorbitol and samples were taken every four hours to make blood smears. These were geimsa-stained to determine the proportions of rings, trophozoites and schizonts at each time point. Parallel smears were stained with the nuclear stain DAPI and simultaneously exposed to the anti-PfPCNA serum. Bound antibody was visualised by fluorescence microscopy after reaction with goat anti-rabbit IgG -M'l'C conjugate. Fig. 6 gives the results of this experiment. As expected, the sample taken four hours after synchronisation was dominated by ring forms. However these steadily declined until after 20 hrs they comprised only ~5% of the parasites. Trophozoites, on the other hand, started at ~4% and increased steadily until 16-20 hrs when they represented -65% of all erythrocytic forms. Schizonts only started to increase in number after 16 hrs had elapsed. Strong immunofluorescence was associated with every schizont observed suggesting that in P.falciparum, as in other eukaryotes, PCNA is present in large amounts when DNA replication is proceeding rapidly. The proportion of undivided parasite nuclei binding the anti-PfPCNA antibody is shown as a percentage below each time point. There was little or no evidence for the synthesis of PfPCNA for the first 12 hours following synchronisation. Thereafter PCNA-associated fluorescence increased rapidly. This increase corresponded with the appearence of mature trophozoites. A correspondence between the patterns of immunofluorescence and the nuclear stain suggests that PfPCNA is confined to the nuclei of the dividing cells. The distribution of PfPCNA in the parasite cell is being examined in greater detail and will reported elsewhere.
DISCUSSION
In an earlier paper (20) we presented data on the molecular cloning and characterisation of DNA polymerase 5 from the malarial parasite, Plasmodium falciparum. In this paper we describe the malarial homologue of PCNA, the auxilliary factor of DNA polymerase 6. PfPCNA is encoded in an open reading frame of 875 nucleotides. There appear to be no introns and RNA blots probed with part of the coding sequence suggest a major transcript of approximately 1.6kb. The gene maps to chromosome 13. A comparison between PfPCNA and those of human, Drosophila, Saccharomyces and Xenopus shows that completely conserved residues are distributed throughout the length of the polypeptide. There are small blocks of conserved residues at both amino and carboxy termini but these are limited to three or four amino acids. Although PCNA does not appear to have a strong affinity for DNA, it has been noted that residues 61 to 79 (boxed in fig. 2 ) may represent a DNA binding domain since they have the potential to form an a helix-turn-a helix (17) . PfPCNA also possesses this feature; 16 of the 20 residues in this region are either identical with those in the human sequence or represent conservative replacements. PfPCNA is longer than its counterparts in the other organisms referred to. Most of the extra residues are inserted in a block near the carboxy terminus of the protein. In some other instances, P.falciparum genes have been shown to contain blocks of inserted amino acids (e.g. PfDNA polymerase a. See ref. 20) . Their significance is at present unclear. The overall identity between PfPCNA and human PCNA is rather low (~34%)asisits identity with the PCNA of yeast (~ 31 %). This may help to explain why antibodies raised against yPCNA (a gift of Dr. Peter Burgers) failed to recognise the same polypeptide as the antiserum raised against the PfPCNA fusion protein described in this report (data not shown).
Antibodies against the fusion between a fragment of PfPCNA and glutathione-S-transferase expressed in E. coli BL21 detected a single band at the predicted position (~ 32kDa) in western blots of total protein from asexual stages of the parasite. Immunofluorescence analysis with this antiserum in synchronous cultures of the parasite has provided a powerful means of both determining the location of PfPCNA in the parasite cell and of timing its appearence relative to nuclear division. The pattern of immunofluorescence suggests that the PfPCNA is restricted to the nuclei in those cells which synthesise it. Fig 6 shows the progression of synchronised cells from ring forms, the only stage to survive the synchronising treatment, through trophozoites and on to schizonts. Attention should be directed to the 12 and 16hr samples in particular. At 12 hours, rings have started to disappear and trophozoites constitute about 35% of the cell population. However even at 12 hours only about 6% of undivided nuclei (rings plus trophozoites) react with the antiserum. At 16 hours, however, trophozoites constitute about 65% of the cell population and 64% of the undivided nuclei appear to be synthesising PCNA. A simple calculation suggests that while only 10% of the trophozoites are synthesising PCNA at 12hrs, > 90% are doing so at 16hrs. These would appear to be trophozoites about to embark on nuclear division because, between 16 and 20 hours after synchronisation, the proportion of erythrocytes containing schizonts, the products of nuclear division (and therefore DNA replication), starts to increase rapidly. Expression of PfPCNA in the malarial parasite is, therefore, cell cycle regulated and takes place first in the nuclei of mature trophozoites. High levels of PfPCNA are maintained throughout sdiizogony. This agrees well with findings in other organisms in which the appearence of PCNA is associated with the onset of DNA replication. Recent studies show that the message associated with PfDNA polymerase a also increases after 27-30 hours post invasion (41) . We estimate that this corresponds approximately with our material at 10-13 hours post-synchronisation.
